These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 1851568

  • 1. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia.
    Collins N, Maher J, Cole M, Baker M, Callaghan N.
    Q J Med; 1991 Feb; 78(286):113-22. PubMed ID: 1851568
    [Abstract] [Full Text] [Related]

  • 2. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D.
    Davie MW, Emberson CE, Lawson DE, Roberts GE, Barnes JL, Barnes ND, Heeley AF.
    Q J Med; 1983 Feb; 52(205):79-91. PubMed ID: 6603629
    [Abstract] [Full Text] [Related]

  • 3. [Vitamin D supplementation in institutionalized elderly. Effects of vitamin D3 (100,000 IU) orally administered every 3 months on serum levels of 25-hydroxyvitamin D].
    Zeghoud F, Jardel A, Garabedian M, Salvatore R, Moulias R.
    Rev Rhum Mal Osteoartic; 1990 Nov; 57(11):809-13. PubMed ID: 1963239
    [Abstract] [Full Text] [Related]

  • 4. Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study.
    Krishnamoorthy G, Nair R, Sundar U, Kini P, Shrivastava M.
    Neurol India; 2010 Nov; 58(2):213-9. PubMed ID: 20508338
    [Abstract] [Full Text] [Related]

  • 5. Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
    Hoikka V, Savolainen K, Karjalainen P, Alhava EM, Sivenius J.
    Ann Clin Res; 1982 Apr; 14(2):72-5. PubMed ID: 6983324
    [Abstract] [Full Text] [Related]

  • 6. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P, Kiely PD.
    Scand J Rheumatol; 2009 Apr; 38(2):149-53. PubMed ID: 18991184
    [Abstract] [Full Text] [Related]

  • 7. Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients.
    Chapuy MC, Chapuy P, Thomas JL, Hazard MC, Meunier PJ.
    Rev Rhum Engl Ed; 1996 Feb; 63(2):135-40. PubMed ID: 8689285
    [Abstract] [Full Text] [Related]

  • 8. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation.
    Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A.
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):609-14. PubMed ID: 8590154
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a new solid formulation of calcium and vitamin D in institutionalized elderly subjects. A randomized comparative trial versus separate administration of both constituents.
    Sebert JL, Garabedian M, Chauvenet M, Maamer M, Agbomson F, Brazier M.
    Rev Rhum Engl Ed; 1995 Apr; 62(4):288-94. PubMed ID: 7606425
    [Abstract] [Full Text] [Related]

  • 10. Anticonvulsant osteomalacia in epileptic outpatients.
    Hoikka V, Savolainen K, Alhava EM, Sivenius J, Karjalainen P, Parvianinen M.
    Ann Clin Res; 1982 Jun; 14(3):129-32. PubMed ID: 7137882
    [Abstract] [Full Text] [Related]

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 12. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium.
    Hillman LS, Cassidy JT, Chanetsa F, Hewett JE, Higgins BJ, Robertson JD.
    Arthritis Rheum; 2008 Oct; 58(10):3255-63. PubMed ID: 18821668
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D prophylaxis in children with a single dose of 150000 IU of vitamin D.
    Oliveri B, Cassinelli H, Mautalen C, Ayala M.
    Eur J Clin Nutr; 1996 Dec; 50(12):807-10. PubMed ID: 8968701
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of hypocalcemia and elevated serum alkaline phosphatase in patients receiving chronic anticonvulsant therapy.
    Schmitt BP, Nordlund DJ, Rodgers LA.
    J Fam Pract; 1984 Jun; 18(6):873-7. PubMed ID: 6726133
    [Abstract] [Full Text] [Related]

  • 15. Anticonvulsant drug therapy in human pregnancy: effects on serum concentrations of vitamin D metabolites in maternal and cord blood.
    Markestad T, Ulstein M, Strandjord RE, Aksnes L, Aarskog D.
    Am J Obstet Gynecol; 1984 Oct 01; 150(3):254-8. PubMed ID: 6091458
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D replacement therapy in patients with the nephrotic syndrome.
    Haldimann B, Trechsel U.
    Miner Electrolyte Metab; 1983 Oct 01; 9(3):154-6. PubMed ID: 6308412
    [Abstract] [Full Text] [Related]

  • 17. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
    Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, Bruland OS, Moan J.
    Lung Cancer; 2007 Mar 01; 55(3):263-70. PubMed ID: 17207891
    [Abstract] [Full Text] [Related]

  • 18. Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis.
    Hanly JG, McKenna MJ, Quigley C, Freaney R, Muldowney FP, FitzGerald MX.
    Q J Med; 1985 Jul 01; 56(219):377-85. PubMed ID: 4095249
    [Abstract] [Full Text] [Related]

  • 19. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
    Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, Holland-Letz T, Weiner SM, Rump LC.
    Nephrol Dial Transplant; 2008 Dec 01; 23(12):4016-20. PubMed ID: 18593741
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
    Hiremath GS, Cettomai D, Baynes M, Ratchford JN, Newsome S, Harrison D, Kerr D, Greenberg BM, Calabresi PA.
    Mult Scler; 2009 Jun 01; 15(6):735-40. PubMed ID: 19383644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.